News and Events | Providence

Upcoming Events

Press

Providence Medical Technology Announces Publication of Two New Studies Supporting Tissue-Sparing Posterior Cervical Fusion

Multiple independent studies demonstrate the results of Providence's tissue-sparing posterior cervical fusion technology.

Providence Medical Technology Secures New Financing of $10.5 Million From Bridge Bank

Proceeds to further commercialize and expand distribution of cervical fusion technology.

Providence Medical Technology Receives New FDA 510(k) Clearances and Bolsters Executive Management Team

Scott Lynch appointed Vice President of Global Marketing and Michael Scott Vice President of International.

Providence Medical Technology Appoints Gregory Curhan Chief Financial Officer

Mr. Curhan brings extensive experience managing high-performing teams and executing acquisition and public offering transactions.

Providence Medical Technology Announces New Equity Financing Of $10.5 Million

Global Healthcare Investor MVM Life Science Partners Leads Round.

Providence Medical Technology Announces the Publication of a Technique Paper

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the publication of “Novel instrumentation and technique for tissue sparing posterior cervical fusion” in the Journal of Clinical Neuroscience by Bruce McCormack, MD and Raman Dhawan, MD.

Providence Medical Technology Announces the Launch of CAVUX™ Cervical Cage-L and DTRAX® Spinal System-L

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the commercial launch of its new CAVUX Cervical Cage-L and DTRAX Spinal System-L.

Providence Medical Technology Announces Presentation of Two-Year Outcomes of Posterior Cervical Fusion for Single-Level Cervical Radiculopathy

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.

Providence Medical Technology Enhances Cervical Fusion Process With Introduction Of Proprietary Surface Technology to DTRAX Line of Tissue Sparing Devices

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today introduced its proprietary Cavux™ surface technology, designed to speed bone fusion during the healing process. The company’s portfolio of DTRAX® Cervical Cage implants will be available with Cavux, a unique surface technology that produces micro-textures on titanium surfaces. The micro- and nanotextures created across the implant surface area serve to enhance the fusion process.

Providence Medical Technology Launches DTRAX Bone Screws to U.S. Market

Providence Medical Technology, Inc. today announced the full commercial launch of DTRAX Bone Screws in the U.S. market.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2024, Providence Medical Technology. All rights reserved.